Rare diseases
Investigational molecules
Locations
Ul. Plowiecka 103, 04-501 Warsaw, Poland
Medical Network Sp. z o.o. in Warsaw, Poland specialises in clinical trials of conditions such as COVID-19 immunisation, Clinical trial participant, Colitis ulcerative, Dyslipidaemia, and other specialisations. This site conducts important research.
At Medical Network Sp. z o.o. researchers are concentrating on ulcerative colitis in pediatric patients, testing a new biologic to improve disease control and safety.
The study seeks to broaden treatment options for children with moderate to severe disease, ultimately enhancing quality of life.
A separate program investigates dyslipidemia in adults at high to very high cardiovascular risk, comparing innovative lipid‑lowering agents to optimize cholesterol management.
Results aim to refine therapeutic approaches for cholesterol disorders and reduce future cardiovascular events.
Clinical trials currently enrolling participants at this site.
Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
PolandStudy of risankizumab safety and effectiveness in children and teenagers aged 2-17 years with moderate to severe ulcerative colitis
PolandSARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
